Paces Ferry Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,040
Closed -$206K 138
2025
Q4
$206K Buy
4,040
+39
+1% +$1.99K 0.08% 126
2025
Q3
$222K Buy
4,001
+387
+11% +$22.7K 0.09% 115
2025
Q2
$249K Sell
3,614
-177
-5% -$12K 0.11% 101
2025
Q1
$263K Buy
3,791
+641
+20% +$52.9K 0.13% 101
2024
Q4
$271K Sell
3,150
-162
-5% -$17.5K 0.13% 101
2024
Q3
$394K Sell
3,312
-20
-0.6% -$2.67K 0.23% 74
2024
Q2
$476K Sell
3,332
-76
-2% -$10.1K 0.29% 61
2024
Q1
$438K Sell
3,408
-172
-5% -$20.5K 0.28% 65
2023
Q4
$370K Sell
3,580
-14
-0.4% -$1.38K 0.26% 72
2023
Q3
$327K Sell
3,594
-108
-3% -$9.51K 0.26% 73
2023
Q2
$300K Sell
3,702
-16
-0.4% -$1.31K 0.22% 84
2023
Q1
$296K Sell
3,718
-56
-1% -$3.97K 0.24% 87
2022
Q4
$255K Buy
+3,774
New +$221K 0.25% 87
2022
Q3
Sell
-3,788
Closed -$211K 100
2022
Q2
$211K Buy
3,788
+50
+1% +$2.77K 0.21% 97
2022
Q1
$208K Sell
3,738
-188
-5% -$9.65K 0.17% 116
2021
Q4
$220K Buy
+3,926
New +$213K 0.16% 107
2020
Q4
Sell
-4,438
Closed -$154K 781
2020
Q3
$154K Buy
+4,438
New +$148K 0.13% 118

Other funds holding NVO

Paces Ferry Wealth Advisors's NVO Position: Q1 2026 in Review

Paces Ferry Wealth Advisors sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,040 shares — an estimated $206K sold.

Paces Ferry Wealth Advisors first reported a position in NVO in Q3 2020 and held it in 17 quarters. The position peaked at $476K in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Paces Ferry Wealth Advisors reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Paces Ferry Wealth Advisors sold 4,040 Novo Nordisk shares in Q1 2026, an estimated $206K.
  • Paces Ferry Wealth Advisors first reported a position in Novo Nordisk in Q3 2020 and held it in 17 quarters.
  • Paces Ferry Wealth Advisors's Novo Nordisk position peaked at $476K in Q2 2024.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Paces Ferry Wealth Advisors's 13F filing for Q1 2026, filed 6 May 2026.